By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Beta-blocker > Propranolol

Propranolol

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|628 words

Propranolol Drug Profile

What is Propranolol?

Propranolol is a non-selective beta-adrenergic receptor blocking agent, commonly known as a beta-blocker. This medication works by blocking the effects of adrenaline and other stress hormones on the heart and blood vessels. It is widely prescribed for treating high blood pressure, heart rhythm disorders, anxiety, and preventing migraines.

Uses

Propranolol has several FDA-approved and well-documented clinical uses:

  • Hypertension (High Blood Pressure): Reduces blood pressure by decreasing heart rate and cardiac output, helping prevent heart attacks, strokes, and kidney problems
  • Angina Pectoris: Prevents chest pain by reducing the heart’s oxygen demand during physical activity or stress
  • Heart Rhythm Disorders: Controls irregular heartbeats including atrial fibrillation and ventricular arrhythmias
  • Migraine Prevention: Reduces the frequency and severity of migraine headaches when taken regularly
  • Performance Anxiety: Helps control physical symptoms of anxiety such as trembling, rapid heartbeat, and sweating in situational anxiety
  • Essential Tremor: Reduces involuntary shaking, particularly in the hands and head

How it works

Propranolol blocks beta-adrenergic receptors in the heart, blood vessels, and other tissues throughout the body. By preventing adrenaline and noradrenaline from binding to these receptors, it reduces heart rate, decreases the force of heart contractions, and relaxes blood vessels. This mechanism helps lower blood pressure, reduce heart workload, and diminish the physical symptoms associated with anxiety and stress.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Fatigue and weakness
  • Dizziness or lightheadedness
  • Cold hands and feet
  • Nausea and stomach upset
  • Sleep disturbances or vivid dreams
  • Decreased exercise tolerance
  • Depression or mood changes
  • Sexual dysfunction

Serious side effects requiring immediate medical attention:

  • Severe bradycardia (very slow heart rate)
  • Severe hypotension (dangerously low blood pressure)
  • Bronchospasm or severe breathing difficulties
  • Heart block or cardiac arrest
  • Severe allergic reactions with swelling and difficulty breathing

Warnings and precautions

  • Contraindicated conditions: Patients with severe asthma, severe COPD, certain heart conditions (severe bradycardia, heart block, cardiogenic shock), or untreated heart failure should not use propranolol
  • Pregnancy and breastfeeding: Classified as FDA Pregnancy Category C; may cause low birth weight and other complications; breastfeeding mothers should consult their healthcare provider as the drug passes into breast milk
  • Diabetes warning: May mask symptoms of low blood sugar (hypoglycemia) and can affect blood glucose levels
  • Sudden discontinuation: Never stop abruptly as this can cause dangerous rebound effects including heart attack, severe high blood pressure, or arrhythmias
  • Surgery considerations: Inform surgeons and anesthesiologists about propranolol use before any surgical procedures

Interactions

  • Calcium channel blockers (verapamil, diltiazem): Can cause severe bradycardia and heart block when combined
  • Insulin and diabetes medications: May enhance hypoglycemic effects and mask warning signs of low blood sugar
  • NSAIDs (ibuprofen, naproxen): Can reduce the blood pressure-lowering effects of propranolol
  • Cimetidine: Increases propranolol blood levels, potentially causing excessive effects
  • Rifampin: Decreases propranolol effectiveness by increasing its metabolism
  • Epinephrine: Can cause severe hypertension and bradycardia in emergency situations
  • Alcohol: May enhance the blood pressure-lowering effects and increase dizziness
  • MAO inhibitors: Can lead to severe hypertensive reactions

Check interactions with the GMJ Interaction Checker

Dosage

Propranolol dosages vary significantly based on the condition being treated and individual patient response. For hypertension, typical starting doses range from 40mg twice daily, with maintenance doses often between 120-240mg daily. For anxiety, lower doses of 10-40mg may be used 30-60 minutes before stressful situations. Migraine prevention typically requires 80-240mg daily in divided doses. Extended-release formulations allow for once-daily dosing in many cases. Dosage adjustments should always be made gradually under medical supervision, and all dosing decisions must be individualized by a qualified healthcare provider based on the patient’s specific medical condition, response to treatment, and other factors.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Propranolol." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/propranolol/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Health Security Agency Launches Evidence-Based Training Programme for Healthcare Staff

The UK Health Security Agency has launched a structured training programme to…

Two Words, One Sector: Why STAT News Keeps ‘Health Care’ Separate

STAT News formalizes editorial convention to maintain 'health care' as two words,…

Tracing transgender identity through history: Evidence from ancient civilizations to modern terminology

Historical records from ancient Egypt, Mesopotamia, Greece, and Rome document individuals who…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Atenolol

By
Prof. Giorgi Pkhakadze
02/06/2026

Sotalol

By
Prof. Giorgi Pkhakadze
02/06/2026

Metoprolol

By
Prof. Giorgi Pkhakadze
02/06/2026

Carvedilol

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up